These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 31486869)

  • 1. Application of CT radiomics in prediction of early recurrence in hepatocellular carcinoma.
    Ning P; Gao F; Hai J; Wu M; Chen J; Zhu S; Wang M; Shi D
    Abdom Radiol (NY); 2020 Jan; 45(1):64-72. PubMed ID: 31486869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma.
    Zhou Y; He L; Huang Y; Chen S; Wu P; Ye W; Liu Z; Liang C
    Abdom Radiol (NY); 2017 Jun; 42(6):1695-1704. PubMed ID: 28180924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomics analysis enables recurrence prediction for hepatocellular carcinoma after liver transplantation.
    Guo D; Gu D; Wang H; Wei J; Wang Z; Hao X; Ji Q; Cao S; Song Z; Jiang J; Shen Z; Tian J; Zheng H
    Eur J Radiol; 2019 Aug; 117():33-40. PubMed ID: 31307650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation.
    Shan QY; Hu HT; Feng ST; Peng ZP; Chen SL; Zhou Q; Li X; Xie XY; Lu MD; Wang W; Kuang M
    Cancer Imaging; 2019 Feb; 19(1):11. PubMed ID: 30813956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT-based radiomics for preoperative prediction of early recurrent hepatocellular carcinoma: technical reproducibility of acquisition and scanners.
    Hu HT; Shan QY; Chen SL; Li B; Feng ST; Xu EJ; Li X; Long JY; Xie XY; Lu MD; Kuang M; Shen JX; Wang W
    Radiol Med; 2020 Aug; 125(8):697-705. PubMed ID: 32200455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
    Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
    EBioMedicine; 2019 Dec; 50():156-165. PubMed ID: 31735556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
    Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
    Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed tomography-based radiomics to predict early recurrence of hepatocellular carcinoma post-hepatectomy in patients background on cirrhosis.
    Qian GX; Xu ZL; Li YH; Lu JL; Bu XY; Wei MT; Jia WD
    World J Gastroenterol; 2024 Apr; 30(15):2128-2142. PubMed ID: 38681988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram.
    Yuan C; Wang Z; Gu D; Tian J; Zhao P; Wei J; Yang X; Hao X; Dong D; He N; Sun Y; Gao W; Feng J
    Cancer Imaging; 2019 Apr; 19(1):21. PubMed ID: 31027510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics model based on contrast-enhanced computed tomography imaging for early recurrence monitoring after radical resection of AFP-negative hepatocellular carcinoma.
    Yan X; Li Y; Qin W; Liao J; Fan J; Xie Y; Wang Z; Li S; Liao W
    BMC Cancer; 2024 Jun; 24(1):700. PubMed ID: 38849749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
    Zhu WS; Shi SY; Yang ZH; Song C; Shen J
    World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomic Features at Contrast-enhanced CT Predict Recurrence in Early Stage Hepatocellular Carcinoma: A Multi-Institutional Study.
    Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
    Radiology; 2020 Mar; 294(3):568-579. PubMed ID: 31934830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A CT-based radiomics nomogram for differentiation of focal nodular hyperplasia from hepatocellular carcinoma in the non-cirrhotic liver.
    Nie P; Yang G; Guo J; Chen J; Li X; Ji Q; Wu J; Cui J; Xu W
    Cancer Imaging; 2020 Feb; 20(1):20. PubMed ID: 32093786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
    Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
    Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of early recurrence of hepatocellular carcinoma after liver transplantation based on computed tomography radiomics nomogram.
    Zhao JW; Shu X; Chen XX; Liu JX; Liu MQ; Ye J; Jiang HJ; Wang GS
    Hepatobiliary Pancreat Dis Int; 2022 Dec; 21(6):543-550. PubMed ID: 35705443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma.
    Peng J; Zhang J; Zhang Q; Xu Y; Zhou J; Liu L
    Diagn Interv Radiol; 2018; 24(3):121-127. PubMed ID: 29770763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules.
    Mokrane FZ; Lu L; Vavasseur A; Otal P; Peron JM; Luk L; Yang H; Ammari S; Saenger Y; Rousseau H; Zhao B; Schwartz LH; Dercle L
    Eur Radiol; 2020 Jan; 30(1):558-570. PubMed ID: 31444598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.
    Wu M; Tan H; Gao F; Hai J; Ning P; Chen J; Zhu S; Wang M; Dou S; Shi D
    Eur Radiol; 2019 Jun; 29(6):2802-2811. PubMed ID: 30406313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy.
    Cozzi L; Dinapoli N; Fogliata A; Hsu WC; Reggiori G; Lobefalo F; Kirienko M; Sollini M; Franceschini D; Comito T; Franzese C; Scorsetti M; Wang PM
    BMC Cancer; 2017 Dec; 17(1):829. PubMed ID: 29207975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT.
    Ma X; Wei J; Gu D; Zhu Y; Feng B; Liang M; Wang S; Zhao X; Tian J
    Eur Radiol; 2019 Jul; 29(7):3595-3605. PubMed ID: 30770969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.